KV Settles DoJ Complaint Over Claims For Unapproved Drugs; Two Dozen Companies Sued
This article was originally published in The Pink Sheet Daily
Executive Summary
The $17 million settlement resolves a False Claims Act suit alleging KV’s Ethex subsidiary illegally received reimbursement for two unapproved drugs; at least three other companies have previously settled with the government.